BlackRock Health Sciences Opportunities Portfolio Class K (SHSKX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
65.15
0.00 (0.00%)
May 30, 2025, 4:00 PM EDT
-11.72%
Fund Assets 6.91B
Expense Ratio 0.75%
Min. Investment $5,000,000
Turnover n/a
Dividend (ttm) 5.88
Dividend Yield 9.02%
Dividend Growth 114.38%
Payout Frequency Semi-Annual
Ex-Dividend Date Dec 11, 2024
Previous Close 65.15
YTD Return -3.30%
1-Year Return -4.35%
5-Year Return 26.05%
52-Week Low 63.27
52-Week High 79.21
Beta (5Y) 0.62
Holdings 145
Inception Date Jun 13, 2016

About SHSKX

The investment seeks to provide long-term growth of capital. The fund invests at least 80% of its total assets in equity securities, primarily common stock, of companies in health sciences and related industries. The health sciences sector can include companies in health care equipment and supplies, health care providers and services, biotechnology, and pharmaceuticals. It will concentrate its investments (i.e., invest more than 25% of its assets) in health sciences or related industries, and may invest in companies located in non-U.S. countries.

Category Health
Stock Exchange NASDAQ
Ticker Symbol SHSKX
Index Russell 3000 Healthcare TR

Performance

SHSKX had a total return of -4.35% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.06%.

Top 10 Holdings

46.42% of assets
Name Symbol Weight
Eli Lilly and Company LLY 8.03%
AbbVie Inc. ABBV 6.91%
Boston Scientific Corporation BSX 5.43%
UnitedHealth Group Incorporated UNH 5.25%
Abbott Laboratories ABT 4.78%
Thermo Fisher Scientific Inc. TMO 3.55%
Stryker Corporation SYK 3.49%
Johnson & Johnson JNJ 3.01%
Amgen Inc. AMGN 2.99%
Gilead Sciences, Inc. GILD 2.98%
View More Holdings

Dividend History

Ex-Dividend Amount Pay Date
Dec 11, 2024 $3.38503 Dec 12, 2024
Jul 18, 2024 $2.49135 Jul 19, 2024
Dec 7, 2023 $1.39964 Dec 8, 2023
Jul 20, 2023 $1.34151 Jul 21, 2023
Dec 8, 2022 $0.28008 Dec 9, 2022
Jul 14, 2022 $4.83356 Jul 15, 2022
Full Dividend History